Temporal analysis of pain responders and common adverse events: when do these first appear following treatment with pregabalin

BACKGROUND: Pregabalin is an α(2)δ ligand indicated in the USA for treatment of a number of chronic pain conditions, including diabetic peripheral neuropathy, postherpetic neuralgia, pain associated with spinal cord injury, and fibromyalgia. A greater understanding of when patients first respond to...

Descripción completa

Detalles Bibliográficos
Autores principales: Parsons, Bruce, Emir, Birol, Clair, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494606/
https://www.ncbi.nlm.nih.gov/pubmed/26170712
http://dx.doi.org/10.2147/JPR.S82806

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494606/
https://www.ncbi.nlm.nih.gov/pubmed/26170712
http://dx.doi.org/10.2147/JPR.S82806

Ejemplares similares